Eukaryotic cell media

TW202637831APending Publication Date: 2026-09-16GENENTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146003
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-23
Filing Date
2025-11-25
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076522_001
    Figure TWG2TA001076522_001
  • Figure TWG2TA001076522_002
    Figure TWG2TA001076522_002
  • Figure TWG2TA001076522_003
    Figure TWG2TA001076522_003
Patent Text Reader

Abstract

This disclosure relates to eukaryotic cell culture media useful in the production of recombinant proteins from cultured cell lines. The eukaryotic cell culture media comprise integrated stress response inhibitor (ISRIB), and / or hypotaurine and / or increased level of iron, and / or suramin. The disclosure also provides methods using said eukaryotic cell culture media, e.g. for culturing mammalian cells with enhanced product titer, and / or growth,and / or viability and / or for producing a recombinant protein of comparable or better product quality by culturing a eukaryotic cell line that comprises a polynucleotide encoding the recombinant protein in said media under conditions suitable for production of the polypeptide. Also provided are use of the eukaryotic cell culture media for the production of a recombinant protein from a cultured cell line comprising a polynucleotide encoding the recombinant protein.
Need to check novelty before this filing date? Find Prior Art